Source: Healthcare Asia Magazine (HCA)

Japan continues to strengthen its position as one of Asia’s most mature medical device markets, with forecasts projecting a valuation of US$42.9 billion by 2029, driven by sustained investment in diagnostics, imaging, and high-value clinical technologies. According to Healthcare Asia, growth will be led by demand for advanced equipment that supports an ageing population, hospital system upgrades, and greater cross-border collaboration across Asia.

For companies targeting expansion in the region – including manufacturers, distributors, and investors – this signal rising opportunities to build partnerships and diversify market reach.

Medical Fair Asia provides an effective platform for industry players to engage with stakeholders from Japan and across the region, enabling exhibitors to profile solutions, meet procurement teams, and strengthen their presence in Asia’s evolving healthcare landscape.